Joint Formulary & PAD

Haloperidol - Schizophrenia and other psychoses

You are here : Home > Formulary Search > Haloperidol - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Off-label use.

Initiation by a Mental Health specialist and stabilisation for at least 1 month before any request to transfer prescribing responsibility.

 

Status 2

Blue
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Capsules are an unlicensed product.

Initiation by a Mental Health specialist and stabilisation for at least 1 month before any request to transfer prescribing responsibility.

 

Status 3

Amber
Formulations :
  • Depot injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Haloperidol decanoate - administration under the shared-care LCS when prescribed in Primary Care.

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Documents :
 
Shared Care
Haloperidol (long-acting injection) for Schizophrenia - AMBER shared care - Oct 2021
 

Status 4

Red
Formulations :
  • Depot injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Haloperidol decanoate - where there is no LCS in place, the prescribing responsibility remains with the Mental Health specialist.

Secondary Care may prescribe for in-patients (on the instruction of a Mental Health specialist) and prescribing continued by the Mental Health specialist after discharge.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Haloperidol
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
depot antipsychotics, antipsychotic depot injections, LAI, shared care
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
4

Committee Recommendations (2)

03 Sep 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of oral anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.

06 Oct 21 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands APC recommends the administration of depot antipsychotic injections under an AMBER shared care agreement for practices that have signed up to the agreed locally commissioned service (LCS).
The updated shared care agreement can be found below.

Surrey Heartlands CCG have developed the LCS to enable stable patients with schizophrenia to be prescribed and administered these injections through their primary care prescriber (GP). 

If a practice has not signed up to the LCS the drug remains as RED status and prescriptions will be issued by the provider.

Other Indications

Below are listed other indications that Haloperidol is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia and other psychoses.